B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ripasudil

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ripasudil, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

fasudil
8 shared targets
hydroxyfasudil
5 shared targets
sar
5 shared targets
y
8 shared targets
capivasertib
8 shared targets
decernotinib
9 shared targets
baricitinib
7 shared targets
ucn
12 shared targets
tofacitinib
8 shared targets
uprosertib
6 shared targets
Loading evidence profile...

This evidence profile for Ripasudil is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.